DPFS applicant guidance: clinical test development and validation (PDF)
If you cannot open or read this document, you can ask for a different format.
In May 2022, MRC conducted a portfolio analysis of applications to the Developmental Pathway Funding Scheme (DPFS) and the associated panel feedback to applicants following review of their proposals. The analysis identified opportunities for applicants to enhance the competitiveness of their DPFS applications across several common challenge areas.
Following consultation with the DPFS panel and other expert stakeholders, this supplementary guidance speaks to these challenge areas and provides additional guidance for applicants applying to DPFS for funding to develop and validate clinical tests.